As head of precision medicine for Merck U.S. Oncology, Dennis Flannelly is thinking ahead. He joins Maria Whitman in this episode to talk about the capability and mindset shifts biopharma needs to make to design, develop and deliver on precision medicine. He also shares the successes he’s seen and what he’s most excited about as precision medicine evolves.
Highlights from the episode:
- Why navigating data will be a key capability in the future
- Where biopharma should focus its energies to advance precision medicine
- Advice for biopharma executives who want to succeed in precision medicine